Unknown

Dataset Information

A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.


ABSTRACT: M-atrial natriuretic peptide (ANP; M-ANP) is a novel next generation 40 amino acid peptide based on ANP, which is highly resistant to enzymatic degradation and has greater and more sustained beneficial actions compared with ANP. The current study was designed to advance our understanding of the therapeutic potential of M-ANP in a canine model of acute angiotensin II-induced hypertension with elevated cardiac filling pressures and aldosterone activation. We compare M-ANP with vehicle and equimolar human B-type natriuretic peptide, which possesses the most potent in vivo actions of the native natriuretic peptides. M-ANP significantly lowered mean arterial pressure and systemic vascular resistance. Importantly, despite a reduction in blood pressure, renal function was enhanced with significan

SUBMITTER: McKie PM 

PROVIDER: S-EPMC4447201 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature